Literature DB >> 9706885

Race and stress in the incidence of herpes zoster in older adults.

K Schmader1, L K George, B M Burchett, J D Hamilton, C F Pieper.   

Abstract

OBJECTIVES: To examine the effect of black race and acute (negative life events) and chronic (lack of social support) psychological stress on the risk of herpes zoster in late life.
DESIGN: A population-based, prospective cohort study.
SETTING: Central North Carolina. PARTICIPANTS: Duke Established Populations for Epidemiological Studies of the Elderly, a stratified probability sample of community-dwelling persons more than 65 years of age. MEASUREMENTS: Interviewers administered a comprehensive health survey to the participants in 1986-1987 (P1, n = 4162), 1989-1990 (P2, n = 3336), and 1992-1994 (P3, n = 2568). Incident cases of zoster between P1 and P2 and P2 and P3 served as the dependent variable. Hypothesis-testing variables included race, negative life events, and five measures of social support. Control variables included age, sex, education, cancer, chronic diseases, basic ADLs, instrumental ADLs, depression, self-rated health, hospitalization, and cigarette smoking. Statistical analyses employed chi-square tests and proportional hazards model.
RESULTS: At baseline, the sample had a mean age of 73.6 years and was 55% black, 45% white, and 65% female. There were 65 cases of zoster between P1 and P2 and 102 cases of zoster between P2 and P3. From P1 to P2, 1.4% of blacks and 3.4% of whites developed zoster (P < .001). From P2 to P3, 2.9% of blacks and 7.5% of whites developed zoster (P < .001). After controlling for the above variables, blacks were significantly less likely to develop zoster (adjusted risk ratio = 0.35; 95% confidence interval (CI), 0.24-0.51; P < .001). Negative life events increased the risk of zoster, but the result was borderline for statistical significance (adjusted RR = 1.38, 95% CI 0.96-1.97; P = .078). No measures of social support were significantly associated with zoster.
CONCLUSION: Black race decreased the risk of zoster in late life significantly. Measures of stress were not significantly related to zoster, but study limitations preclude definitive conclusions. Future research should focus on these factors in larger samples and different populations.

Entities:  

Mesh:

Year:  1998        PMID: 9706885     DOI: 10.1111/j.1532-5415.1998.tb02751.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  23 in total

Review 1.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

Review 2.  Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.

Authors:  Giovanni Gabutti; Paolo Bonanni; Michele Conversano; Guido Fanelli; Elisabetta Franco; Donato Greco; Giancarlo Icardi; Marzia Lazzari; Alessandro Rossi; Silvestro Scotti; Antonio Volpi
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

3.  Herpes zoster and postherpetic neuralgia: an examination of psychological antecedents.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2014-05

4.  Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.

Authors:  Michael R Irwin; Myron J Levin; Mark L Laudenslager; Richard Olmstead; Anne Lucko; Nancy Lang; Carmen Carrillo; Harold A Stanley; Michael J Caulfield; Adriana Weinberg; Ivan S F Chan; Jim Clair; Jeff G Smith; R D Marchese; Heather M Williams; Danielle J Beck; Patricia T McCook; Jane H Zhang; Gary Johnson; Michael N Oxman
Journal:  Clin Infect Dis       Date:  2013-02-13       Impact factor: 9.079

5.  Balanitis is a risk factor for herpes zoster.

Authors:  C-Y Hsu; C-L Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-18       Impact factor: 3.267

6.  Major depressive disorder and immunity to varicella-zoster virus in the elderly.

Authors:  Michael R Irwin; Myron J Levin; Carmen Carrillo; Richard Olmstead; Anne Lucko; Nancy Lang; Michael J Caulfield; Adriana Weinberg; Ivan S F Chan; Jim Clair; Jeff G Smith; R D Marchese; Heather M Williams; Danielle J Beck; Patricia T McCook; Gary Johnson; Michael N Oxman
Journal:  Brain Behav Immun       Date:  2011-02-15       Impact factor: 7.217

Review 7.  Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.

Authors:  Anne A Gershon; Michael D Gershon; Judith Breuer; Myron J Levin; Anne Louise Oaklander; Paul D Griffiths
Journal:  J Clin Virol       Date:  2010-05       Impact factor: 3.168

8.  Vibrio vulnificus necrotizing fasciitis preceding herpes zoster.

Authors:  Kelli Y Ha; Stephen K Tyring
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-01

9.  Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Authors:  Myron J Levin; Jeffrey P Anderson; George R Seage; Paige L Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

10.  Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.

Authors:  M J Levin; M N Oxman; J H Zhang; G R Johnson; H Stanley; A R Hayward; M J Caulfield; M R Irwin; J G Smith; J Clair; I S F Chan; H Williams; R Harbecke; R Marchese; S E Straus; A Gershon; A Weinberg
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.